Achieve Life Sciences, Inc. (ACHV)
Largest Insider Buys in Sector
ACHV Stock Price History Chart
ACHV Stock Performance
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
Insider Activity of Achieve Life Sciences, Inc.
Over the last 12 months, insiders at Achieve Life Sciences, Inc. have bought $91,700 and sold $0 worth of Achieve Life Sciences, Inc. stock.
On average, over the past 5 years, insiders at Achieve Life Sciences, Inc. have bought $40,300 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Bencich John (CEO) — $45,850. Stewart Richard Alistair (Executive Chairman) — $45,850.
The last purchase of 10,000 shares for transaction amount of $45,850 was made by Bencich John (CEO) on 2024‑03‑04.
List of Insider Buy and Sell Transactions, Achieve Life Sciences, Inc.
| 2024-03-04 | CEO | 10,000 0.0492% | $4.58 | $45,850 | +3.03% | |||
| 2024-03-04 | Executive Chairman | 10,000 0.0492% | $4.58 | $45,850 | +3.03% | |||
| 2023-05-30 | CEO | 5,000 0.0246% | $5.50 | $27,500 | -26.44% | |||
| 2022-11-18 | CEO | 22,000 – | $0 | $0 | +107.53% | |||
| 2021-05-27 | CEO | 6,000 0.0716% | $7.00 | $42,000 | -3.40% | |||
| 2019-06-11 | Sale | 10 percent owner | 312,145 4.6633% | $3.11 | $972,288 | -71.03% | ||
| 2019-06-11 | 10 percent owner | 12,813 0.2335% | $3.80 | $48,689 | -71.03% | |||
| 2019-05-23 | Chairman & CEO | 17,500 0.2417% | $3.61 | $63,093 | -74.93% | |||
| 2016-08-19 | Sale | CFO | 2,760 0.0092% | $0.57 | $1,573 | -21.05% | ||
| 2016-06-13 | Sale | President and CEO | 9,712 0.032% | $1.03 | $9,959 | -50.96% | ||
| 2016-06-13 | Sale | EVP, CMO | 2,874 0.0095% | $1.03 | $2,947 | -50.96% | ||
| 2016-03-15 | Sale | President and CEO | 24,066 0.0807% | $0.83 | $19,975 | -30.12% | ||
| 2016-03-15 | Sale | EVP, CMO | 6,508 0.0218% | $0.83 | $5,402 | -30.12% | ||
| 2016-03-15 | Sale | CFO | 1,668 0.0056% | $0.83 | $1,384 | -30.12% | ||
| 2015-08-18 | Sale | CFO | 2,854 0.0103% | $2.76 | $7,877 | -62.45% | ||
| 2015-06-12 | Sale | President and CEO | 9,142 0.0381% | $2.69 | $24,592 | -56.36% | ||
| 2015-06-12 | Sale | EVP, CMO | 2,816 0.0117% | $2.69 | $7,575 | -56.36% | ||
| 2015-05-20 | Sale | President and CEO | 15,086 0.0639% | $1.88 | $28,362 | +11.11% | ||
| 2015-05-20 | Sale | EVP, CMO | 4,184 0.0177% | $1.88 | $7,866 | +11.11% | ||
| 2014-08-13 | Sale | President and CEO | 36,682 0.1682% | $3.17 | $116,282 | -30.49% |
Insider Historical Profitability
| Bencich John | CEO | 76724 0.2231% | $3.69 | 4 | 3 | <0.0001% |
| Stewart Richard Alistair | Executive Chairman | 38501 0.112% | $3.69 | 2 | 0 | <0.0001% |
| COHEN STEVEN A/SAC CAPITAL MGMT LP | 10 percent owner | 1454752 4.2302% | $3.69 | 1 | 0 | |
| S A C CAPITAL MANAGEMENT L L C | 10 percent owner | 1454752 4.2302% | $3.69 | 1 | 0 | |
| SAC CAPITAL ADVISORS LLC | 10 percent owner | 1454752 4.2302% | $3.69 | 1 | 0 |
Institutional Investor Ownership
| Franklin Templeton Investments | $17.19M | 17.37 | 5.96M | New | +$17.19M | 0.01 | |
| Sofinnova | $6.9M | 4.42 | 1.52M | New | +$6.9M | 0.01 | |
| The Vanguard Group | $4.31M | 2.76 | 948,441 | +56.58% | +$1.56M | <0.0001 | |
| Altium Capital Management Lp | $3.8M | 2.43 | 835,470 | New | +$3.8M | 0.45 | |
| Nantahala Capital Management Llc | $2.97M | 1.9 | 654,000 | New | +$2.97M | 0.14 |